Illumina inc stock.
17 equities research analysts have issued 1 year price targets for Illumina's shares. Their ILMN share price targets range from $100.00 to $328.00. On average, they predict the company's share price to reach $194.56 in the next year. This suggests a possible upside of 77.2% from the stock's current price.
Illumina's genomic technologies enable better pathogen preparedness and response. SAN DIEGO, May 16, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response.Illumina, Inc. Stock price Equities ILMN US4523271090 Advanced Medical Equipment & Technology Market Closed ...Date. Title. Nov 14, 2023. Illumina To Webcast Upcoming Investor Conferences. Nov 13, 2023. Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries. Nov 9, 2023. Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023. Nov 1, 2023.Aug 18, 2021 · The base stock consideration was subject to a collar, where the number of shares issued at closing varied in the event the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is between $295 and $399 but was fixed at 11.3 million shares if such volume weighted average share price is above $399 ...
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325 Weaker Guidance Dragged Illumina (ILMN) in Q3. (Insider Monkey) Nov-16-23 04:50PM. Illumina: Company Investigated by the Portnoy Law Firm. (GlobeNewswire) 10:15AM. Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors.
Innovative technologies. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers.Illumina Company Info. Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function.
Illumina Company Info. Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. Weaker Guidance Dragged Illumina (ILMN) in Q3. (Insider Monkey) Nov-16-23 04:50PM. Illumina: Company Investigated by the Portnoy Law Firm. (GlobeNewswire) 10:15AM. Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors.ILLUMINA INC 0J8Z Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Discover Start your journey hereGet the latest news and real-time alerts from Illumina, Inc. (ILMN) stock at Seeking Alpha.
View the latest Illumina Inc. (ILMN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Live Chat Inc. is a tool you can use to interact with customers or clients on the internet. More and more, consumers are demanding and expecting immediate help from the companies they approach. This application enables you to engage with cu...
Company profile page for Illumina Inc including stock price, company news, press releases, executives, board members, and contact informationIllumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Nov 29, 2023 · Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 7.17% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.55 and as low as $89.00. Year to date, Illumina, Inc.’s stock ... Apr 3, 2023 · As the uncertainty over the fate of Grail has dragged on, Illumina’s stock price has declined by 37 percent over the past year. Illumina shares, which traded below $200 a share before Mr. Icahn ... Apple Inc. Common Stock. $178.29 +0.73 +0.41%. Illumina, Inc. Common Stock (ILMN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global ...
Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. San Diego, CA. 5001 to 10000 Employees. 15 Locations. Type: Company - Public (ILMN) Founded in 1998. Revenue: $1 to $5 billion (USD) Biotech & Pharmaceuticals. Competitors: Thermo Fisher Scientific, Roche, Thermo Fisher Scientific, Roche Create Comparison. Illumina is a global leader in genomics—an industry at the intersection of biology and ...To learn more, visit illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube. Investors: Salli Schwartz 858-291-6421 [email protected]. Media: David McAlpine 347-327-1336. Samantha Beal 714-227-2661 [email protected] - Illumina Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ... As Illumina stock bounces off a 10-year low, analysts see no quick fix MarketWatch. Friday, November 10, 2023. 10:16 AM ET. Illumina’s stock on track for lowest close in 10 years after cutting guidance MarketWatch ...33 Undervalued Stocks. Here’s the new list of Morningstar’s top underpriced analyst picks for Q4 2023. Susan Dziubinski. Oct 3, 2023. The U.S. stock market finished the third quarter of 2023 ...
Find the latest Illumina, Inc. (ILMN) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.On August 10, 2023, Illumina revealed that the SEC was investigating the Company's statements regarding GRAIL, including "conduct and compensation of certain members of Illumina and GRAIL management."
On August 10, 2023, Illumina revealed that the SEC was investigating the Company's statements regarding GRAIL, including "conduct and compensation of certain members of Illumina and GRAIL management."Track Illumina Inc (ILMN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief …This 38% fall for ILMN stock since late 2019 can primarily be attributed to 1. the company’s P/S ratio falling 50% to 6.8x trailing revenues now, vs. 13.7x in 2019, 2. a 7.2% rise in its average ...Best genomics stocks of 2023. Data source: The Motley Fool. Data current as of June 14, 2023. Genomics Company. Market Capitalization. Description. Illumina ( NASDAQ:ILMN ) $32.4 billion. Industry ...SAN DIEGO-- (BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These changes will be effective as of the Company’s Annual Shareholder Meeting …Illumina’s stock value declined, which drew the ire of shareholders, like Icahn. The complaint names Illumina’s former CEO, Francis deSouza, and former chairman of the board, John W. Thompson ...
Illumina's shares rose 2.2% to $204.98 in premarket trading on Monday. The company's shares have lost about 60% of their value since completing the Grail deal in 2021.
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) certain of the Company's insiders had personal financial motives for acquiring GRAIL, Inc.; (2) contrary to Illumina's attempts to discount Icahn's criticism, Icahn had …
ILMN - Illumina Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ... As Illumina stock bounces off a 10-year low, analysts see no quick fix MarketWatch. Friday, November 10, 2023. 10:16 AM ET. Illumina’s stock on track for lowest close in 10 years after cutting guidance MarketWatch ...The gun-jumping cost Illumina a record EU antitrust fine of 432 million euros ($457 million) for such an offence. The EU competition enforcer subsequently blocked the $7.1 billion deal in 2022 on ...Jan 7, 2013 · SAN DIEGO--(BUSINESS WIRE)--Jan. 7, 2013-- Illumina, Inc. (NASDAQ:ILMN) today announced that it has signed a definitive agreement to acquire Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million plus up to $100 million in milestone ... As of June 30, 2023, Illumina's financial statement reveals some key figures. The company's long-term debt stands at $1.49 billion, while its current debt Best stocks to buy nowHeadquartered in San Diego, California, Illumina, Inc. (NASDAQ:ILMN) is a biotechnology company. On October 20, 2022, Illumina, Inc. (NASDAQ:ILMN) stock closed at $208.64 per share. One-month ...9.12M. BABA. 72.93. -2.60%. 9.87M. View today's Illumina Inc stock price and latest ILMN news and analysis. Create real-time notifications to follow any changes in the live stock price.EU regulators will order US biotech Illumina to sell cancer test developer Grail after it bought the $8bn company without the approval of Brussels, according to three people with direct knowledge ...December 19, 2017. SAN DIEGO -- (BUSINESS WIRE)--Dec. 19, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast. J.P. Morgan Healthcare Conference Presentation, San Francisco, California. Monday, January 8, 2018 at 3:30 pm ...Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022. Nov 3, 2022. Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis. GAAP diluted loss per share of $ (24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 ...Illumina Inc (ILMN) Stock Analysis: Strong Buy Rating and Potential Price Increase Expected in Q4 2023. On October 12, 2023, Illumina Inc (ILMN) stock had a last price of $131.65. The 19 analysts offering 12-month price forecasts for ILMN have a median target of $200.00, with a high estimate of $318.00 and a low estimate of $100.00. The …
Transcript : Illumina, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 11:30 AM Nov. 29: CI Transcript : Illumina, Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 10:50 AM Nov. 28: CISee Illumina, Inc. (ILMN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.... Inc. and finanzen.net GmbH (Imprint). All rights reserved. Registration on ... Stock quotes by finanzen.net · Contact Us · Masthead · Your Privacy Choices.Instagram:https://instagram. bug light stockdental insurance massachusettsroger greendavid karp ILLUMINA INC 0J8Z Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. stock predictioninvestment property companies Interactive Chart for Illumina, Inc. (ILMN), analyze all the data with a huge range of indicators. Stock Price Forecast. According to 15 stock analysts, the average 12-month stock price forecast for Illumina stock is $200.33, which predicts an increase of 82.47%. The lowest target is $100 and the highest is $334. On average, analysts rate Illumina stock as … future stock splits On this news, the Company’s stock price fell $7.42, or 5.6%, to close at $124.45 per share on October 18, 2023. What Now: Similarly situated shareholders may be eligible to participate in the class action against Illumina, Inc. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. Plaintiffs must file their ...The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. (“Illumina”) (NASDAQ: ILMN).The action charges Illumina with violations of the federal securities …EPS: -$4.77 in Q3 vs. -$24.26 in the same period last year. Excluding items, Illumina Inc. reported adjusted earnings of $52 million or $0.33 per share for the period. Analysts projected $0.12 per ...